Imperial College London


Faculty of MedicineDepartment of Brain Sciences

Research Associate







Burlington DanesHammersmith Campus





I received a Bsc (Hons) in Cognitive neuroscience and psychology from the University of Manchester in 2015 and was awarded with a PhD in neuropsychopharmacology from the same university in 2019. I was the recipient of the highly competitive President’s Doctoral Scholars Award, which partly funded my PhD studies. Throughout my PhD, I investigated the effects of chronic treatment with antipsychotics on cognition and its neural correlates in an animal model for cognitive impairment associated with schizophrenia using a combination of behavioural and in-vivo electrophysiological techniques.

I am now a research associate working with Dr Samuel Barnes in the Dementia Research Institute (UK DRI) at Imperial College. We use a combination of in-vivo calcium imaging, electrophysiological and behavioural techniques to investigate the dynamics of homeostatic neural plasticity in aging and neurodegeneration.



Doostdar N, Kim E, Grayson B, et al., 2019, Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory, Journal of Psychopharmacology, Vol:33, ISSN:0269-8811, Pages:1274-1287

Cadinu D, Grayson B, Podda G, et al., 2018, NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update, Neuropharmacology, Vol:142, ISSN:0028-3908, Pages:41-62

Sahin C, Doostdar N, Neill JC, 2016, Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model, Behavioural Brain Research, Vol:312, ISSN:0166-4328, Pages:93-101

More Publications